Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03199599
NCT03199599
Completed
Not Applicable

Prognostic Positron Emission Tomography/Computed Tomogrpahy Model in Non Small Cell Lung Cancer

Poitiers University Hospital1 site in 1 country150 target enrollmentSeptember 1, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNon Small Cell Lung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non Small Cell Lung Cancer
Sponsor
Poitiers University Hospital
Enrollment
150
Locations
1
Primary Endpoint
validation of a multiparametric PET/CT prognostic model
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Prospective validation of a prognostic model based on advanced PET/CT image analysis in non small cell lung cancer

Detailed Description

Validation on a prospective cohort of patient of a predictive model for survival based on image derived parameters

Registry
clinicaltrials.gov
Start Date
September 1, 2016
End Date
August 31, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •non small cell lung cancer
  • •initial fluorodeoxygluoces (FDG) PET/CT before treatment
  • •exclusion criteria:

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

validation of a multiparametric PET/CT prognostic model

Time Frame: 18 months

overall survival rate

Study Sites (1)

Loading locations...

Similar Trials

Terminated
Not Applicable
PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic FootDiabetic FootOsteoarthritis
NCT01322256Centre Hospitalier Universitaire de Nīmes12
Completed
Not Applicable
Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung AdenocarcinomaStage I Pulmonary Adenocarcinoma
NCT04202614IRCCS San Raffaele58
Recruiting
Not Applicable
The value of CTPET scans for the prediction of response after treatment in rectal cancer.Pathologic complete response, prediction, rectal cancer, machine learning, chemoradiotherapy, PET
NL-OMON24449Maastro Clinic Dr.Tanslaan 126229 ET Maastricht500
Terminated
Phase 2
Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35Lung CancerMetastatic Cancer
NCT00958321Cancer Trials Ireland40
Completed
Not Applicable
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue SarcomaSarcoma
NCT00346125Masonic Cancer Center, University of Minnesota70